Laurion Capital Management LP purchased a new position in Hamilton Lane Incorporated (NASDAQ:HLNE – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,416 shares of the company’s stock, valued at approximately $358,000.
A number of other hedge funds also recently modified their holdings of HLNE. CBIZ Investment Advisory Services LLC grew its position in Hamilton Lane by 27.0% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 287 shares of the company’s stock valued at $43,000 after acquiring an additional 61 shares during the last quarter. Farther Finance Advisors LLC grew its position in Hamilton Lane by 283.3% in the fourth quarter. Farther Finance Advisors LLC now owns 299 shares of the company’s stock valued at $44,000 after acquiring an additional 221 shares during the last quarter. Kapitalo Investimentos Ltda bought a new position in Hamilton Lane in the fourth quarter valued at about $65,000. R Squared Ltd bought a new position in Hamilton Lane in the fourth quarter valued at about $213,000. Finally, Aigen Investment Management LP bought a new position in Hamilton Lane in the fourth quarter valued at about $221,000. Institutional investors own 97.40% of the company’s stock.
Analyst Ratings Changes
A number of research firms have issued reports on HLNE. Wells Fargo & Company decreased their target price on Hamilton Lane from $152.00 to $147.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 8th. Oppenheimer upgraded Hamilton Lane from a “market perform” rating to an “outperform” rating and set a $186.00 target price on the stock in a research report on Tuesday, January 21st. Keefe, Bruyette & Woods lifted their target price on Hamilton Lane from $158.00 to $168.00 and gave the company a “market perform” rating in a research report on Wednesday, February 5th. Morgan Stanley decreased their target price on Hamilton Lane from $190.00 to $157.00 and set an “equal weight” rating on the stock in a research report on Monday, April 14th. Finally, JPMorgan Chase & Co. cut their price target on Hamilton Lane from $176.00 to $167.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 29th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, Hamilton Lane currently has an average rating of “Hold” and an average price target of $164.14.
Hamilton Lane Stock Performance
Shares of HLNE stock opened at $162.68 on Monday. The business’s 50-day moving average price is $146.43 and its 200-day moving average price is $159.88. Hamilton Lane Incorporated has a 12 month low of $114.28 and a 12 month high of $203.72. The firm has a market capitalization of $9.02 billion, a price-to-earnings ratio of 30.01 and a beta of 1.31. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.34.
Hamilton Lane Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, April 4th. Stockholders of record on Friday, March 14th were paid a dividend of $0.49 per share. This represents a $1.96 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date of this dividend was Friday, March 14th. Hamilton Lane’s payout ratio is 36.16%.
Hamilton Lane Profile
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Featured Stories
- Five stocks we like better than Hamilton Lane
- Stock Splits, Do They Really Impact Investors?
- Constellation Powers Up With Reinforced AI Data Center Strategy
- How to Read Stock Charts for Beginners
- Top Analyst-Rated Healthcare Stocks to Watch Now
- Insider Trading – What You Need to Know
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Want to see what other hedge funds are holding HLNE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hamilton Lane Incorporated (NASDAQ:HLNE – Free Report).
Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.